18:34:07 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-29 Kvartalsrapport 2024-Q3
2024-08-30 Kvartalsrapport 2024-Q2
2024-05-31 Kvartalsrapport 2024-Q1
2024-05-29 Ordinarie utdelning POLAR 0.00 SEK
2024-05-28 Årsstämma 2024
2024-02-23 Bokslutskommuniké 2023
2023-11-24 Kvartalsrapport 2023-Q3
2023-09-08 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-26 Kvartalsrapport 2023-Q1
2023-05-17 Årsstämma 2023
2023-05-05 Ordinarie utdelning POLAR 0.00 SEK
2023-03-13 Extra Bolagsstämma 2022
2023-02-24 Bokslutskommuniké 2022
2022-11-25 Kvartalsrapport 2022-Q3
2022-08-26 Kvartalsrapport 2022-Q2
2022-05-27 Kvartalsrapport 2022-Q1
2022-05-06 Ordinarie utdelning POLAR 0.00 SEK
2022-05-05 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-27 Kvartalsrapport 2021-Q2
2021-05-28 Kvartalsrapport 2021-Q1
2021-05-06 Ordinarie utdelning POLAR 0.00 SEK
2021-05-05 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-11-27 Kvartalsrapport 2020-Q3
2020-08-28 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning POLAR 0.00 SEK
2020-06-30 Årsstämma 2020
2020-05-29 Kvartalsrapport 2020-Q1
2020-02-28 Bokslutskommuniké 2019
2020-02-14 Extra Bolagsstämma 2020
2019-10-23 Kvartalsrapport 2019-Q3
2019-07-24 Kvartalsrapport 2019-Q2
2019-05-07 Split POLAR 16:1
2019-04-26 Kvartalsrapport 2019-Q1
2019-03-19 Årsstämma 2019
2019-02-04 Ordinarie utdelning POLAR 0.00 SEK
2019-02-01 Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Polarcool är verksamt inom medicinteknik. Idag är bolaget inriktade mot att produkter och lösningar inriktade för skador inom sport och aktivitet. Störst fokus återfinns inom forskning och utveckling av produkter som används vid behandling av hjärnskador vid exempelvis boxning, rugby och amerikansk fotboll. Verksamhet innehas på global nivå, med störst närvaro inom den europeiska marknaden.
2021-09-28 12:16:00

PolarCool AB (publ) has made a break-through with PolarCap® System on the French market within rugby. The company has signed a subsidized evaluation agreement with the French professional rugby club Stade Français. The agreement means that the French capital club will use the PolarCap® System for an initial six-week period with the aim to subsequently sign a commercial agreement.

The agreement with Stade Français also implies that during this initial period they will introduce PolarCap® System to other clubs in the French first league. Thus, PolarCool deems that there are good opportunities for a broader establishment in the country.

PolarCool has established a close contact with Stade Français'medical chief, Dr Elliot Rubio. He has been presented with and evaluated the scientific background and the clinical evidence of PolarCap® System.

The agreement is a result of PolarCool's marketing strategy with agents in different markets. The French agreement has been signed through Jamie Bache, a former elite rugby player from the UK with a wide network of contacts in European rugby. Jamie is also the company's representative for rugby in the UK, where discussions currently are pursued for the best way to introduce PolarCap® System in the country. He has also worked as a Sports Marketing Account Manager for Umbro and his network of contacts is even broad within British football.

PolarCool's CEO Erik Andersson comments:

- The fact that we have now received a proposal from a top French rugby team to start using the PolarCap® System means that we have taken an important step towards establishing the company on a new market. Our experience is also that those who start providing PolarCap® System reckon its benefits and are willing to continue with the treatment. The fact that Stade Français and their doctor, Dr Elliot Rubio, also will introduce the treatment to other clubs is an important part of the agreement and of great value to the company.

Stade Français' doctor, Dr Elliot Rubio comments:

- I am grateful that the Stade Fraçais Paris, as the first rugby organization in France, can start providing the PolarCap® system to our players. We welcome the PolarCap® system as a new tool for the acute treatment of concussions and are convinced that we can thus offer improved medical care for our players.